CompletedNCT01352637
Enhancing Exposure Therapy for PTSD (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer
Medication studyAges 18–70United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- Long Beach, United States · Los Angeles, United States and 3 more locationsSee all locations and recruitment
- Activities
- Medication described in the protocol · Placebo comparator
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateStarted: May 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 192
- Sponsor
- Weill Medical College of Cornell University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT01352637
- Official title
Show the full official title
Enhancing Exposure Therapy for PTSD: Virtual Reality and Imaginal Exposure With a Cognitive Enhancer
Recruitment & locations
CompletedLong Beach · Los Angeles · Atlanta
2 more locations
- Bethesda
- New York
Questions about this study
Who is behind this study?
The study sponsor is Weill Medical College of Cornell University, a university.
Did this study involve medication?
Yes. The study involved medication, including DCS (D-Cycloserine ) + Prolonged Imaginal Exposure, DCS (D-Cycloserine ) + Virtual Reality Exposure, Placebo + Prolonged Imaginal Exposure and Placebo (sugar pill) + Virtual Reality Exposure.
Who was this study for?
Listed age limits: 18 years to 70 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT01861847
7-Keto DHEA for PTSD
United States
CompletedNCT03508700
TNX-102 SL 5.6 mg Taken Daily at Bedtime for PTSD
United States
CompletedNCT00554177
A study for PTSD
United States